{"id":"eye-drops-lubricant","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Eye irritation or stinging"},{"rate":null,"effect":"Allergic reaction (rare)"}]},"_chembl":{"chemblId":"CHEMBL2107924","moleculeType":"Unknown"},"_dailymed":{"setId":"4de5c844-85ca-ff9f-e063-6394a90ac12c","title":"ARTIFICIAL TEARS LUBRICANT EYE DROPS (GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [KC PHARMACEUTICALS, INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lubricant eye drops contain viscous agents (such as carboxymethylcellulose, hyaluronic acid, or mineral oil) that mimic natural tears and coat the cornea and conjunctiva. They reduce friction between the eyelid and eye surface, decrease evaporation of tear film, and provide symptomatic relief of dry eye symptoms. These drops do not address underlying tear production deficiency but provide temporary comfort and protection.","oneSentence":"Lubricating eye drops provide moisture and form a protective film over the ocular surface to relieve dryness and irritation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T06:01:14.543Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / Keratoconjunctivitis sicca"},{"name":"Ocular irritation and discomfort"}]},"trialDetails":[{"nctId":"NCT07495852","phase":"PHASE3","title":"Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2026-02-17","conditions":"Glaucoma","enrollment":510},{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":"Dry Eye Disease (DED)","enrollment":260},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":"Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive","enrollment":100},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":"Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases","enrollment":2410},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":"Dry Eye Syndromes","enrollment":200},{"nctId":"NCT05577910","phase":"NA","title":"Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-10-08","conditions":"Meibomian Gland Dysfunction","enrollment":374},{"nctId":"NCT06819046","phase":"","title":"Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment","status":"COMPLETED","sponsor":"Colorado Ophthalmology Associates PC","startDate":"2025-02-14","conditions":"Glaucoma","enrollment":70},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":"Dry Eye Disease","enrollment":55},{"nctId":"NCT06792903","phase":"EARLY_PHASE1","title":"YM-101 Eye Drops in the Treatment of Dry Eye Syndrome","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-04-23","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT07284381","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-12-15","conditions":"Dry Eye Disease","enrollment":250},{"nctId":"NCT07469865","phase":"NA","title":"Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-11-30","conditions":"Dry Eye Disease","enrollment":46},{"nctId":"NCT07463950","phase":"PHASE4","title":"A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2026-01-20","conditions":"Dry Eye Disease (DED)","enrollment":25},{"nctId":"NCT07238699","phase":"NA","title":"An Evaluation of the Safety and Tolerability of Ocular Lubricants","status":"RECRUITING","sponsor":"Alcon Research","startDate":"2026-03-04","conditions":"Dry Eye Disease","enrollment":148},{"nctId":"NCT07451184","phase":"PHASE4","title":"Comparison of Ocular Lubricants in People With Symptoms of Dry Eye","status":"RECRUITING","sponsor":"University of Waterloo","startDate":"2026-02-23","conditions":"Dry Eye Symptoms","enrollment":100},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":"Dry Eye, Insulin","enrollment":116},{"nctId":"NCT07075718","phase":"PHASE2, PHASE3","title":"Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2025-06-12","conditions":"Glaucoma","enrollment":610},{"nctId":"NCT06637423","phase":"PHASE1, PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":"Non-Muscle Invasive Bladder Cancer","enrollment":32},{"nctId":"NCT07422259","phase":"NA","title":"Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed","status":"COMPLETED","sponsor":"Medivis SRL","startDate":"2025-06-09","conditions":"Keratoconjunctivitis Sicca","enrollment":40},{"nctId":"NCT06444516","phase":"NA","title":"Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-09-04","conditions":"Dry Eye Disease","enrollment":188},{"nctId":"NCT07413172","phase":"PHASE2","title":"Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-03","conditions":"Dry Eye, Eye Diseases, Eyes Dry Chronic","enrollment":20},{"nctId":"NCT07264517","phase":"PHASE2","title":"Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).","status":"RECRUITING","sponsor":"Instituto Grifols, S.A.","startDate":"2025-11-03","conditions":"Dry Eye Disease","enrollment":100},{"nctId":"NCT07382453","phase":"PHASE2","title":"Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2026-02-15","conditions":"Diabetic Keratopathy","enrollment":30},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":"Acanthamoeba Keratitis","enrollment":232},{"nctId":"NCT06428409","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":"Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer","enrollment":220},{"nctId":"NCT05414994","phase":"","title":"Assessment of the Ocular Microbiome in Health and Disease","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-09-07","conditions":"Microbial Colonization, Eye Diseases, Ophthalmopathy","enrollment":500},{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":"Diabetic Retinopathy","enrollment":164},{"nctId":"NCT06163989","phase":"NA","title":"Protecting the Eyes of Gamers With Lubricating Eyedrops","status":"RECRUITING","sponsor":"Aston University","startDate":"2024-09-01","conditions":"Dry Eye Syndromes, Computer Vision Syndrome","enrollment":28},{"nctId":"NCT03697876","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-08-20","conditions":"Dry Eye Syndromes","enrollment":32},{"nctId":"NCT07234318","phase":"","title":"Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears","status":"NOT_YET_RECRUITING","sponsor":"Laboratoires Thea","startDate":"2025-12-15","conditions":"Dry Eye Disease (DED)","enrollment":25},{"nctId":"NCT06886373","phase":"PHASE4","title":"Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-03-25","conditions":"Ophthalmology","enrollment":140},{"nctId":"NCT07229001","phase":"NA","title":"Treating Meibomian Gland Disease in a Pediatric Population","status":"ENROLLING_BY_INVITATION","sponsor":"Illinois College of Optometry","startDate":"2024-10-01","conditions":"Dry Eye Disease, Meibomian Gland Disease","enrollment":15},{"nctId":"NCT02118922","phase":"","title":"A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2013-06","conditions":"Keratoconus, Ectasia, Crosslinking","enrollment":168},{"nctId":"NCT04968912","phase":"PHASE2","title":"A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-21","conditions":"Sjogren's Syndrome","enrollment":163},{"nctId":"NCT05999630","phase":"PHASE3","title":"Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-08-21","conditions":"Nasolacrimal Duct Obstruction, Thyroid Cancer","enrollment":100},{"nctId":"NCT07078955","phase":"PHASE2","title":"A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"BRIM Biotechnology Inc.","startDate":"2025-12","conditions":"Dry Eye Disease (DED), Keratoconjunctivitis Sicca","enrollment":99},{"nctId":"NCT04440280","phase":"PHASE2","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2020-09-16","conditions":"Fuchs Endothelial Corneal Dystrophy","enrollment":45},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Ocular Surface Disease","enrollment":61},{"nctId":"NCT06876077","phase":"NA","title":"Evaluation of the Effectiveness of Auricular Acupuncture in Improving Dry Eye Symptoms in University Students","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2025-03-15","conditions":"Dry Eye Symptoms","enrollment":50},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT07185854","phase":"NA","title":"Medical vs Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Nadide Koca","startDate":"2024-01-15","conditions":"Dry Eye, Acupuncture","enrollment":90},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":"Age-Related Macular Degeneration","enrollment":64},{"nctId":"NCT05938699","phase":"PHASE2, PHASE3","title":"Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution","status":"COMPLETED","sponsor":"Nicox Ophthalmics, Inc.","startDate":"2023-12-12","conditions":"Open Angle Glaucoma","enrollment":18},{"nctId":"NCT05902364","phase":"NA","title":"Systane® Ultra Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-10-28","conditions":"Dry Eye","enrollment":69},{"nctId":"NCT06571656","phase":"NA","title":"Evaluation of the Safety and Tolerability of Ocular Lubricants","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2025-04-02","conditions":"Dry Eye Disease","enrollment":73},{"nctId":"NCT06676917","phase":"PHASE2","title":"Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases","status":"WITHDRAWN","sponsor":"MedSIR","startDate":"2025-06","conditions":"Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT07110467","phase":"NA","title":"Nursing Intervention of Blinking Exercises to Alleviate Dry Eye and Enhance Daily Life in Older Adults","status":"COMPLETED","sponsor":"Norther Private Collage of Nursing","startDate":"2024-11-01","conditions":"Daily Activities, Eye Health","enrollment":100},{"nctId":"NCT07064187","phase":"PHASE4","title":"Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery","status":"COMPLETED","sponsor":"Nguyen Viet Giap","startDate":"2022-06-15","conditions":"Ocular Discomfort","enrollment":100},{"nctId":"NCT07090044","phase":"PHASE4","title":"Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period","status":"COMPLETED","sponsor":"Retina Research Institute, LLC","startDate":"2021-08-20","conditions":"Vein Occlusion, Macular Degeneration Choroidal Neovascularization, Macular Edema","enrollment":77},{"nctId":"NCT05682547","phase":"NA","title":"Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye","status":"COMPLETED","sponsor":"He Eye Hospital","startDate":"2022-12-01","conditions":"Diabetic Eye Problems","enrollment":99},{"nctId":"NCT06913387","phase":"NA","title":"Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Evaporative Dry Eye","enrollment":60},{"nctId":"NCT07048886","phase":"PHASE4","title":"Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)","status":"NOT_YET_RECRUITING","sponsor":"Center for Sight Las Vegas","startDate":"2025-07-15","conditions":"Primary Open Angle Glaucoma","enrollment":68},{"nctId":"NCT05896670","phase":"PHASE2","title":"Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Oculis","startDate":"2023-11-29","conditions":"Dry Eye Disease","enrollment":122},{"nctId":"NCT06865144","phase":"PHASE4","title":"Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT","status":"RECRUITING","sponsor":"East Coast Institute for Research","startDate":"2025-06-27","conditions":"Primary Open Angle Glaucoma or Ocular Hypertension","enrollment":70},{"nctId":"NCT06655441","phase":"PHASE4","title":"The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function","status":"NOT_YET_RECRUITING","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2025-09-01","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT01013077","phase":"NA","title":"The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability","status":"COMPLETED","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2009-11","conditions":"Dry Eye Syndrome","enrollment":20},{"nctId":"NCT07000565","phase":"NA","title":"The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-11-01","conditions":"Ocular Surface Disease","enrollment":42},{"nctId":"NCT06989827","phase":"NA","title":"Impact of DED on the Accuracy of Preoperative Keratometry Values in the Calculation of IOL Power for Cataract Surgery.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Sestre Milosrdnice","startDate":"2025-06-02","conditions":"Dry Eye Disease (DED), Cataract","enrollment":100},{"nctId":"NCT06960629","phase":"","title":"The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital Dubrava","startDate":"2025-04-01","conditions":"Pseudophakic Bullous Keratopathy, Glaucoma","enrollment":50},{"nctId":"NCT05773963","phase":"NA","title":"A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease","status":"TERMINATED","sponsor":"Montefarmaco OTC SpA","startDate":"2022-02-24","conditions":"Opthalomology/Dry Eye","enrollment":80},{"nctId":"NCT06969586","phase":"","title":"The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital Dubrava","startDate":"2025-04-01","conditions":"Fuchs Endothelial Corneal Dystrophy, Cataract, Glaucoma","enrollment":50},{"nctId":"NCT03368404","phase":"NA","title":"A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye","status":"COMPLETED","sponsor":"Laboratoire Chauvin","startDate":"2017-11-09","conditions":"Dry Eye","enrollment":92},{"nctId":"NCT06956846","phase":"PHASE4","title":"Efficacy of Topical Insuline in Corneal Epithelial Healing Post PRK","status":"NOT_YET_RECRUITING","sponsor":"Hotel Dieu de France Hospital","startDate":"2025-04-25","conditions":"Corneal Epithelial Wound Healing","enrollment":100},{"nctId":"NCT06955585","phase":"NA","title":"Efficacy of Lipid-containing Artificial Tears in the Treatment of Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Sestre Milosrdnice","startDate":"2025-04-25","conditions":"Dry Eye Disease, Dry Eye, Dry Eye, Evaporative","enrollment":50},{"nctId":"NCT06543667","phase":"PHASE1","title":"Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye","status":"RECRUITING","sponsor":"Iran University of Medical Sciences","startDate":"2024-08-01","conditions":"Dry Eye Syndromes","enrollment":30},{"nctId":"NCT05814367","phase":"PHASE2","title":"Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2023-04-06","conditions":"Visual Acuity","enrollment":46},{"nctId":"NCT05661851","phase":"PHASE2","title":"Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2023-02-23","conditions":"Dry Eye","enrollment":121},{"nctId":"NCT06939959","phase":"PHASE4","title":"Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-04-14","conditions":"Dry Eye, Insulin Sensitivity","enrollment":126},{"nctId":"NCT06921525","phase":"PHASE1, PHASE2","title":"Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Ehab Mohamed Elsayed Mohamed Saad","startDate":"2025-04-01","conditions":"Dry Eye","enrollment":44},{"nctId":"NCT06219577","phase":"PHASE4","title":"Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance","status":"COMPLETED","sponsor":"Scripps Poway Eyecare and Optometry","startDate":"2024-01-18","conditions":"Dry Eye","enrollment":70},{"nctId":"NCT06913556","phase":"NA","title":"Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Dry Eye Syndrome","enrollment":64},{"nctId":"NCT06914232","phase":"NA","title":"Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Dry Eye Syndrome","enrollment":54},{"nctId":"NCT05932225","phase":"NA","title":"Systane® Complete Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-08-18","conditions":"Dry Eye","enrollment":71},{"nctId":"NCT06898853","phase":"NA","title":"The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes","status":"NOT_YET_RECRUITING","sponsor":"The University of New South Wales","startDate":"2025-05-01","conditions":"Dry Eye Disease (DED)","enrollment":60},{"nctId":"NCT01207752","phase":"NA","title":"The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2010-09","conditions":"Meibomian Gland Dysfunction","enrollment":69},{"nctId":"NCT06688630","phase":"NA","title":"Laser Acupuncture for Dry Eye Disease Due to Visual Display Terminal Use","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-12-27","conditions":"Dry Eye Syndromes","enrollment":45},{"nctId":"NCT06163105","phase":"NA","title":"The Effect of Gland Expression on the Regeneration of Meibomian Gland","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-10-03","conditions":"Meibomian Gland Dysfunction","enrollment":64},{"nctId":"NCT05705518","phase":"PHASE4","title":"Artificial Tears, Tear Lipids and Tear Film Dynamics","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2023-01-30","conditions":"Dry Eye","enrollment":81},{"nctId":"NCT06860659","phase":"PHASE4","title":"Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye","status":"ENROLLING_BY_INVITATION","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2024-09-01","conditions":"Dry Eye Disease (DED), Tear Break-Up Time, Tear Disorder","enrollment":84},{"nctId":"NCT05832996","phase":"PHASE4","title":"Cool vs Room-temperature Artificial Tears","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2022-03-01","conditions":"Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative Age-Related Macular Degeneration, Unspecified Eye","enrollment":124},{"nctId":"NCT06851364","phase":"PHASE2","title":"Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants","status":"COMPLETED","sponsor":"International Islamic University Malaysia","startDate":"2022-10-30","conditions":"Dry Eye","enrollment":45},{"nctId":"NCT06671041","phase":"PHASE4","title":"Treating Lid Wiper Epitheliopathy","status":"COMPLETED","sponsor":"Southern College of Optometry","startDate":"2024-05-27","conditions":"Dry Eye, Visual Acuity","enrollment":52},{"nctId":"NCT06824844","phase":"PHASE4","title":"The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2021-12-02","conditions":"Dry Eye","enrollment":60},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT02707120","phase":"PHASE4","title":"Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis","status":"WITHDRAWN","sponsor":"Biotechnology Institute IMASD","startDate":"2018-01-04","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT00607776","phase":"PHASE2","title":"Artificial Tears Study in Mild to Moderate Dry Eye Patients","status":"COMPLETED","sponsor":"Abbott Medical Optics","startDate":"2007-01","conditions":"Dry Eye","enrollment":110},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT06784661","phase":"PHASE4","title":"Immediate Effects of Lipid-Based and Non-Lipid Artificial Tears on Corneal Aberrations","status":"NOT_YET_RECRUITING","sponsor":"University of Seville","startDate":"2025-02-01","conditions":"Aberration, Corneal Wavefront","enrollment":40},{"nctId":"NCT06752278","phase":"NA","title":"Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-01","conditions":"Dry Eye Disease (DED)","enrollment":40},{"nctId":"NCT06726525","phase":"PHASE4","title":"Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study","status":"COMPLETED","sponsor":"University of Milan","startDate":"2024-02-03","conditions":"Dry Eye","enrollment":44},{"nctId":"NCT03031327","phase":"NA","title":"Safety and Efficacy of 2 Concentrations of Lubricin vs Sodium Hyaluronate in Ocular Discomfort After Refractive Surgery.","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2017-06-17","conditions":"Ocular Discomfort","enrollment":30},{"nctId":"NCT06720428","phase":"NA","title":"Acupoint Therapy Device for Dry Eye","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2021-01-01","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT06188260","phase":"PHASE2","title":"Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-01-16","conditions":"Dry Eye Syndromes","enrollment":31},{"nctId":"NCT04237012","phase":"PHASE4","title":"ACCURATE Study for Subjects With Dry Eyes","status":"COMPLETED","sponsor":"The Eye Centers of Racine and Kenosha","startDate":"2019-12-16","conditions":"Dry Eye Syndromes","enrollment":30},{"nctId":"NCT06686368","phase":"PHASE4","title":"Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"I-MED Pharma","startDate":"2024-11-15","conditions":"Evaporative Dry Eye Disease","enrollment":60},{"nctId":"NCT06656403","phase":"NA","title":"Effect of Artificial Tears on Ocular Biometry Parameters","status":"NOT_YET_RECRUITING","sponsor":"He Eye Hospital","startDate":"2024-10-30","conditions":"Dry Eye Disease, Tear Film","enrollment":100},{"nctId":"NCT06017362","phase":"PHASE4","title":"Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors","status":"RECRUITING","sponsor":"Barbara Burgos Blasco","startDate":"2023-02-08","conditions":"Dry Eye, Glaucoma","enrollment":100},{"nctId":"NCT03374306","phase":"NA","title":"Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2018-02-01","conditions":"Myopia","enrollment":71}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Eye Drops, Lubricant","genericName":"Eye Drops, Lubricant","companyName":"Eximore Ltd.","companyId":"eximore-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lubricating eye drops provide moisture and form a protective film over the ocular surface to relieve dryness and irritation. Used for Dry eye syndrome / Keratoconjunctivitis sicca, Ocular irritation and discomfort.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}